{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:49:11Z","timestamp":1790498951039,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.idc.2006.07.004","type":"journal-article","created":{"date-parts":[[2007,1,13]],"date-time":"2007-01-13T19:44:10Z","timestamp":1168717450000},"page":"485-506","source":"Crossref","is-referenced-by-count":218,"title":["Invasive Candidiasis"],"prefix":"10.1016","volume":"20","author":[{"given":"Peter G.","family":"Pappas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idc.2006.07.004_bib1","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1086\/497138","article-title":"The changing face of fungal infections in health care settings","volume":"41","author":"Fridkin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib2","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1086\/313450","article-title":"The epidemiology of candidemia in two United States cities: results of a population-based active surveillance","volume":"29","author":"Kao","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib3","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/JCM.40.4.1298-1302.2002","article-title":"Epidemiology of candidemia: 3-year results from the Emerging Infections and the Epidemiology of Iowa Organisms study","volume":"40","author":"Diekema","year":"2002","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.idc.2006.07.004_bib4","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/513663","article-title":"The epidemiology of hematogenous candidiasis caused by different Candida species","volume":"24","author":"Abi-Said","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib5","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1086\/502581","article-title":"Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance","volume":"26","author":"Morgan","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2006.07.004_bib6","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1128\/JCM.40.9.3489-3492.2002","article-title":"Increasing incidence of candidemia: results of 20 year nationwide study in Iceland","volume":"40","author":"Asmundsdottir","year":"2002","journal-title":"J Clin Micro"},{"key":"10.1016\/j.idc.2006.07.004_bib7","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/376906","article-title":"A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients","volume":"37","author":"Pappas","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10096-004-1103-y","article-title":"Epidemiology of candidemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study","volume":"23","author":"Tortorano","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib9","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1086\/342300","article-title":"Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989\u20131999","volume":"35","author":"Trick","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib11","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1086\/496922","article-title":"The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis","volume":"41","author":"Zaoutis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/520192","article-title":"Nosocomial bloodstream infections in United States hospitals: a three-year analysis","volume":"29","author":"Edmond","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib13","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/archsurg.137.12.1353","article-title":"Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care","volume":"137","author":"Harbarth","year":"2002","journal-title":"Arch Surg"},{"key":"10.1016\/j.idc.2006.07.004_bib14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1439-0507.2001.00662.x","article-title":"Trends in species causing fungemia in a tertiary care medical centre over 12 years","volume":"44","author":"Malani","year":"2002","journal-title":"Mycoses"},{"key":"10.1016\/j.idc.2006.07.004_bib15","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idc.2006.07.004_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/315193","article-title":"Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole","volume":"181","author":"Marr","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib17","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1086\/514731","article-title":"Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organizaiton for Research and Treatment of Cancer (EORTC)","volume":"28","author":"Viscoli","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3201\/eid0702.010203","article-title":"The impact of hospital-acquired bloodstream infections","volume":"7","author":"Wenzel","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.md.0000091182.93122.8e","article-title":"Candidemia in a tertiary care center: in vitro susceptibility and its association with outcome of initial antifungal therapy","volume":"82","author":"Antoniadou","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.idc.2006.07.004_bib20","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1128\/JCM.43.9.4434-4440.2005","article-title":"Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and number of isolates with reduced azole susceptibility","volume":"43","author":"Arendrup","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2006.07.004_bib21","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s10096-003-0973-8","article-title":"Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for treatment of invasive candidiasis","volume":"22","author":"Colombo","year":"2003","journal-title":"Eur J\u00a0Clin Micro"},{"key":"10.1016\/j.idc.2006.07.004_bib22","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/JCM.42.4.1519-1527.2004","article-title":"Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program","volume":"42","author":"Hajjeh","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2006.07.004_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/380637","article-title":"Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991\u20132000","volume":"38","author":"Marchetti","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib24","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1128\/JCM.42.7.3142-3146.2004","article-title":"Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002","volume":"42","author":"Pfaller","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2006.07.004_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1469-0691.2002.00446.x","article-title":"Candidemia in French hospitals: incidence rates and characteristics","volume":"8","author":"Richet","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idc.2006.07.004_bib26","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1128\/JCM.39.3.949-953.2001","article-title":"Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results from a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada","volume":"39","author":"St. Germain","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2006.07.004_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/jhin.2002.1261","article-title":"European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region","volume":"51","author":"Tortorano","year":"2002","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.idc.2006.07.004_bib28","first-page":"493","article-title":"Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992\u20131994","volume":"160","author":"Yamamura","year":"1999","journal-title":"CMAJ"},{"key":"10.1016\/j.idc.2006.07.004_bib29","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/378745","article-title":"Attributable mortality of nosocomial candidemia, revisited","volume":"37","author":"Gudlaugsson","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib30","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1001\/archinte.148.12.2642","article-title":"Hospital-acquired candidemia: the attributable mortality and excess length of stay","volume":"148","author":"Wey","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.idc.2006.07.004_bib31","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/clinids\/20.6.1531","article-title":"Nosocomial candidemia: risk factors and attributable mortality","volume":"20","author":"Wenzel","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s10096-003-0885-7","article-title":"Estimating attributable mortality of candidemia: clinical judgment vs. matched cohort studies","volume":"22","author":"Blot","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/322606","article-title":"Trends in mortality due to invasive mycotic diseases in the United States, 1980\u20131997","volume":"33","author":"McNeil","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib34","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1086\/496935","article-title":"Candidemia is costly-plain and simple","volume":"41","author":"Fridkin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib35","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1128\/AAC.46.6.1723-1727.2002","article-title":"In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp","volume":"46","author":"Pfaller","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2006.07.004_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1470-9465.2004.t01-1-00844.x","article-title":"Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida","volume":"10","author":"Pfaller","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idc.2006.07.004_bib37","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1128\/JCM.42.7.3117-3119.2004","article-title":"Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolates","volume":"42","author":"Pfaller","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2006.07.004_bib38","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1128\/JCM.42.8.3607-3612.2004","article-title":"Comparison of results of fluconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS Global Antifungal Surveillance Program","volume":"42","author":"Pfaller","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2006.07.004_bib39","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1128\/JCM.43.11.5425-5427.2005","article-title":"In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole","volume":"43","author":"Pfaller","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2006.07.004_bib40","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1128\/JCM.43.12.5848-5859.2005","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing","volume":"43","author":"Pfaller","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2006.07.004_bib41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/clinids\/20.1.115","article-title":"Importance of Candida species other than C. albicans as pathogens in oncology patients","volume":"20","author":"Wingard","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib42","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00006454-199509000-00009","article-title":"Neonatal Candida parapsilosis outbreak with a high case fatality rate","volume":"14","author":"Saxen","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.idc.2006.07.004_bib43","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1086\/323812","article-title":"Risk factors for Candida tropicalis fungemia in patients with cancer","volume":"33","author":"Kontoyiannis","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib44","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005792-199907000-00002","article-title":"Candida glabrata fungemia: clinical features of 139 patients","volume":"78","author":"Gumbo","year":"1999","journal-title":"Medicine"},{"key":"10.1016\/j.idc.2006.07.004_bib45","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1128\/IAI.37.2.833-836.1982","article-title":"Differences in virulence of clinical isolates of Candida tropicalis and Candida albicans in mice","volume":"37","author":"Wingard","year":"1982","journal-title":"Infect Immun"},{"key":"10.1016\/j.idc.2006.07.004_bib46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/321811","article-title":"Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS Prospective Multicenter Study","volume":"33","author":"Blumberg","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib47","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00003246-199906000-00019","article-title":"Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients","volume":"27","author":"Eggimann","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idc.2006.07.004_bib48","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00000658-199412000-00008","article-title":"Candida colonization and subsequent infections in critically ill surgical patients","volume":"220","author":"Pittet","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.idc.2006.07.004_bib49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00006454-200004000-00011","article-title":"Risk factors for candidemia in neonatal intensive care unit patients","volume":"19","author":"Saiman","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.idc.2006.07.004_bib50","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/JCM.40.4.1244-1248.2002","article-title":"Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources","volume":"40","author":"Shin","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2006.07.004_bib51","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1128\/AAC.48.9.3291-3297.2004","article-title":"Penetration of Candida biofilms by antifungal agents","volume":"48","author":"Al-Fattani","year":"2004","journal-title":"Antimicrob Agent Chemo"},{"key":"10.1016\/j.idc.2006.07.004_bib52","first-page":"109","article-title":"Type 1 and type 2 cytokines: from basic science to fungal infections","volume":"36","author":"Murphy","year":"1998","journal-title":"Med Mycol"},{"issue":"Suppl 2","key":"10.1016\/j.idc.2006.07.004_bib53","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/S0190-9622(08)81260-1","article-title":"Chronic mucocutaneous candidiasis","volume":"31","author":"Kirkpatrick","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.idc.2006.07.004_bib54","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/infdis\/166.3.668","article-title":"Neutrophil oxidative burst in response to blastoconidia and pseudohyphae of C. albicans: augmentation by GCSF and interferon gamma","volume":"166","author":"Roilides","year":"1992","journal-title":"J\u00a0Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2006.07.004_bib55","first-page":"S174","article-title":"Cytokines and mycoses","volume":"36","author":"Stevens","year":"1998","journal-title":"Med Mycol"},{"key":"10.1016\/j.idc.2006.07.004_bib56","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1007\/s00134-002-1540-y","article-title":"Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive-decontamination","volume":"28","author":"Garbino","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.idc.2006.07.004_bib57","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00000658-200104000-00010","article-title":"Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients","volume":"233","author":"Pelz","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.idc.2006.07.004_bib58","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/01.CCM.0000202435.98240.ED","article-title":"Multifocal Candida species colonization as a trigger for early antifungal therapy in critically ill patients: what about other risk factors for fungal infection?","volume":"34","author":"Charles","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idc.2006.07.004_bib59","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","article-title":"A bedside scoring system (\u201cCandida score\u201d) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization","volume":"34","author":"Leon","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idc.2006.07.004_bib60","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/BF02013057","article-title":"Predictive value of surveillance cultures for systemic infection due to Candida species","volume":"6","author":"Pfaller","year":"1987","journal-title":"Eur J Clin Microbiol"},{"key":"10.1016\/j.idc.2006.07.004_bib61","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/003655401750065544","article-title":"Candidemia before and during the fluconazole era: prevalence, types of species and approach to treatment in a tertiary care community hospital","volume":"33","author":"Baran","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib62","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/jac\/dki473","article-title":"Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?","volume":"57","author":"Charlier","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idc.2006.07.004_bib63","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","article-title":"Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole","volume":"325","author":"Wingard","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idc.2006.07.004_bib64","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/AAC.37.9.1847","article-title":"Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients","volume":"37","author":"Wingard","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2006.07.004_bib65","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.12.1.80","article-title":"Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans","volume":"12","author":"Fidel","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.idc.2006.07.004_bib66","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0732-8893(93)90020-8","article-title":"Lysis-centrifugation blood cultures in the detection of proven invasive candidiasis: disseminated versus single organ infection","volume":"17","author":"Berenguer","year":"1993","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib67","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/432470","article-title":"Multicenter clinical evaluation of the (1\u20133) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans","volume":"41","author":"Ostrosky-Zeichner","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2006.07.004_bib68","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1128\/JCM.43.6.2909-2912.2005","article-title":"Multicenter evaluation of a Candida albicans peptide nucleic acid fluorescent in situ hybridization probe for characterization of yeast isolates from blood cultures","volume":"43","author":"Wilson","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2006.07.004_bib69","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2174\/138945005774912708","article-title":"Antifungal susceptibility testing methods","volume":"6","author":"Pfaller","year":"2005","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.idc.2006.07.004_bib70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0732-8893(98)00120-5","article-title":"Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B","volume":"32","author":"Pfaller","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib71","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1128\/JCM.42.11.4977-4979.2004","article-title":"Evaluation of the Etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida species","volume":"42","author":"Pfaller","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2006.07.004_bib72","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/JCM.44.3.760-763.2006","article-title":"In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance","volume":"44","author":"Pfaller","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2006.07.004_bib73","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/JCM.44.3.819-826.2006","article-title":"Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints","volume":"44","author":"Pfaller","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2006.07.004_bib74","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","article-title":"Guidelines for treatment of candidiasis","volume":"38","author":"Pappas","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib75","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1086\/499057","article-title":"Current treatment strategies for disseminated candidiasis","volume":"42","author":"Spellberg","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib76","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0002-9343(98)00030-8","article-title":"Predictors of adverse outcome in cancer patients with candidemia","volume":"104","author":"Anaissie","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.idc.2006.07.004_bib77","doi-asserted-by":"crossref","first-page":"91","DOI":"10.7326\/0003-4819-89-1-91","article-title":"Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy","volume":"89","author":"Edwards","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.idc.2006.07.004_bib78","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/clinids\/19.4.697","article-title":"Candida tropicalis vertebral osteomyelitis: a late sequela of fungemia","volume":"19","author":"Ferra","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib79","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1086\/322634","article-title":"Vertebral osteomyelitis due to Candida species: case report and literature review","volume":"33","author":"Miller","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib80","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1001\/archinte.149.10.2226","article-title":"Prospective study of Candida endophthalmitis in hospitalized patients with candidemia","volume":"149","author":"Brooks","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.idc.2006.07.004_bib81","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00005792-197401000-00002","article-title":"Ocular manifestations of candida septicemia: review of 26 cases of hematogenous candida endophthalmitis","volume":"53","author":"Edwards","year":"1974","journal-title":"Medicine"},{"key":"10.1016\/j.idc.2006.07.004_bib82","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0891-5520(05)70128-8","article-title":"Hepatosplenic candidiasis: a manifestation of chronic disseminated candidiasis","volume":"14","author":"Kontoyiannis","year":"2000","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.idc.2006.07.004_bib83","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0002-9343(76)90728-2","article-title":"Candida arthritis: a manifestation of disseminated candidiasis","volume":"60","author":"Murray","year":"1976","journal-title":"Am J Med"},{"key":"10.1016\/j.idc.2006.07.004_bib84","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/clinids\/21.2.323","article-title":"Meningitis caused by Candida species: an emerging problem in neurosurgical patients","volume":"21","author":"Nguyen","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib85","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-199305000-00001","article-title":"Primary candida pneumonia","volume":"72","author":"Haron","year":"1993","journal-title":"Medicine"},{"key":"10.1016\/j.idc.2006.07.004_bib86","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(05)67490-9","article-title":"Voriconazole versus a regimen of amphotericin B\u00a0followed by fluconazole for candidemia in non-neutropenic patients: a randomized non-inferiority trial","volume":"366","author":"Kullberg","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2006.07.004_bib87","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1086\/367933","article-title":"Voriconazole: a new triazoles antifungal agent","volume":"36","author":"Johnson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib88","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.diagmicrobio.2003.09.008","article-title":"In vitro activities of voriconazole, posaconazole, and fluconazole against 4169 clinical isolates of Candida spp. and C. neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program","volume":"48","author":"Pfaller","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib89","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1517\/14656566.6.10.1657","article-title":"Echinocandins: role in antifungal therapy, 2005","volume":"6","author":"Zaas","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.idc.2006.07.004_bib90","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idc.2006.07.004_bib91","unstructured":"Runke M, Kuse E, Chetchotisakd P, et al. Comparison of micafungin and liposomal amphotericin B for invasive candidiasis. Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy [abstract M-722C]. Washington, DC, December 17\u201320, 2005."},{"key":"10.1016\/j.idc.2006.07.004_bib92","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1517\/13543784.12.8.1313","article-title":"The echinocandin antifungals: an overview of the pharmacology, spectrum, and clinical efficacy","volume":"12","author":"Wiederhold","year":"2003","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.idc.2006.07.004_bib93","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/AAC.49.2.767-769.2005","article-title":"Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis","volume":"49","author":"Moudgal","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2006.07.004_bib94","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1086\/500939","article-title":"Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient","volume":"42","author":"Krogh-Madsen","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib95","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199411173312001","article-title":"A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia","volume":"331","author":"Rex","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idc.2006.07.004_bib96","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF01726360","article-title":"Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients","volume":"16","author":"Phillips","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib97","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/374850","article-title":"A randomized and blinded multicenter trial of high dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in non-neutropenic patients","volume":"36","author":"Rex","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib98","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1086\/368312","article-title":"Continuous infusion of escalated doses of amphotericin B deoxycholate: an open-label observational study","volume":"36","author":"Imhof","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib99","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00019048-200009040-00006","article-title":"Fluconazole prophylaxis of severe candida infections in trauma and post-surgical patients: prospective, double blind, randomized, placebo controlled trial","volume":"9","author":"Able","year":"2000","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.idc.2006.07.004_bib100","doi-asserted-by":"crossref","first-page":"R710","DOI":"10.1186\/cc3883","article-title":"The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis","volume":"9","author":"Ho","year":"2005","journal-title":"Crit Care"},{"key":"10.1016\/j.idc.2006.07.004_bib101","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10096-004-1215-4","article-title":"Prophylaxis and treatment of invasive candidiasis in the intensive care setting","volume":"23","author":"Ostrosky-Zeichner","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib102","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1086\/421956","article-title":"Clinical trials of antifungal prophylaxis among patients in surgical intensive care units: concepts and considerations","volume":"39","author":"Lipsett","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2006.07.004_bib103","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jac\/dki491","article-title":"Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials","volume":"57","author":"Playford","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idc.2006.07.004_bib104","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1097\/01.CCM.0000147726.62304.7F","article-title":"Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients","volume":"32","author":"Piarroux","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idc.2006.07.004_bib105","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/01.CCM.0000178352.14703.49","article-title":"Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis","volume":"33","author":"Shorr","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idc.2006.07.004_bib106","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/01.CCM.0000208357.05675.C3","article-title":"Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials","volume":"34","author":"Vardakas","year":"2006","journal-title":"Crit Care Med"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552006000626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552006000626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T18:52:12Z","timestamp":1587322332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552006000626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":106,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0891552006000626"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2006.07.004","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}